Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease
Conditions
- Chronic Graft Versus Host Disease
Interventions
- DRUG: Belumosudil
- PROCEDURE: Biospecimen Collection
- OTHER: Electronic Health Record Review
- DRUG: Placebo Administration
Sponsor
Fred Hutchinson Cancer Center
Collaborators